Terug
Dagbereik
€ 4,95
€ 5,30
52-Weeksbereik
€ 1,29
€ 7,18
Volume
2.576.357
50D / 200D Gem.
€ 5,73
/
€ 3,77
Vorige Slotkoers
€ 5,37
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,3 | 0,3 |
| P/B | 2,0 | 2,9 |
| ROE % | -50,8 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 16,00
+220.0%
Forward WPA
-€ 0,93
Omzet Sch.
3,2 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,79
€ 0,79 – € 0,79
|
480 M | 4 |
| FY2028 |
€ 0,14
-€ 0,49 – € 1,03
|
260 M | 6 |
| FY2027 |
-€ 0,59
-€ 0,84 – -€ 0,37
|
63 M | 7 |
Belangrijkste Punten
Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -118,02M
PEG of 0,12 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-50,84%
ROIC-35,88%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,10
Current Ratio10,37
Interest Coverage0,00
Waardering
P/E Ratio
-4,33
P/B Ratio2,04
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -138,20M |
| ROE | -50,84% | ROA | -39,48% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -118,02M |
| ROIC | -35,88% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 10,37 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,33 | P/B Ratio | 2,04 |
| P/S Ratio | N/A | PEG Ratio | 0,12 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 597,98M | Enterprise Value | 577,45M |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -138,20M | -134,24M | -141,95M | -130,32M | -63,41M |
| EPS (Diluted) | -1,01 | -1,77 | -2,60 | -3,34 | -3,70 |
| Gross Profit | -3,45M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -154,07M | -143,72M | -145,60M | -130,71M | -63,47M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 350,07M | 297,67M | 285,10M | 287,04M | 355,95M |
| Total Liabilities | 56,97M | 47,12M | 53,90M | 55,13M | 11,67M |
| Shareholders' Equity | 293,11M | 250,56M | 231,19M | 231,91M | 344,28M |
| Total Debt | 28,97M | 31,36M | 32,86M | 34,59M | 0,0 |
| Cash & Equivalents | 49,50M | 225,11M | 140,02M | 74,84M | 268,57M |
| Current Assets | 316,46M | 263,86M | 248,10M | 247,69M | 354,01M |
| Current Liabilities | 30,51M | 17,93M | 22,36M | 21,74M | 10,62M |